Concepedia

Gianfranco Fornasini

GF

Statistics

Publications

10

Citations

695

H-Index

10

Active since

1993

Affiliations

University of South Australia(Current)

Sigma-Tau Pharmaceuticals (United States)

Screen

Zambon (Italy)

Royal Adelaide Hospital

Gianfranco Fornasini is an author at University of South Australia specializing in pharmacology, medicine, and pharmacokinetics.

Publications per year

1993–2020

10

Publications

10

Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis

Marcus A. Bain, Randall Faull, Gianfranco Fornasini et al. · Nephrology Dialysis Transplantation · 2006 · 284 citations

, , +13

Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease

Allan M. Evans, Randall Faull, Roger L. Nation et al. · Kidney International · 2004 · 77 citations

, , +9

The use of pharmacoscintigraphy to focus the development strategy for a novel 5-ASA colon targeting system (“TIME CLOCK®” system)

K.P. Steed, G. Hooper, N. Monti et al. · Journal of Controlled Release · 1997 · 67 citations

, , +4

Determination of the reference range of endogenous plasma carnitines in healthy adults

Stephanie E. Reuter, Allan M. Evans, Donald H. Chace et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2008 · 59 citations

, , +12

Relationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver.

Chu-Yang Chou, Allan M. Evans, Gianfranco Fornasini et al. · Drug Metabolism and Disposition · 1993 · 52 citations

, , +17

1–5 of 10